Molecular coronary MR imaging of human thrombi using EP-2104R, a fibrin-targeted contrast agent: Experimental study in a swine model

RoFo Fortschritte auf dem Gebiet der Rontgenstrahlen und der Bildgebenden Verfahren

Volumn 179, Issue 11, 2007, Pages 1166-1173

  Spuentrup, Elmar ^a,b,c   Katoh, M ^b,d   Wiethoff, A J ^e   Buecker, A ^a,d   Botnar, R M ^f,g   Parsons, E C ^e   Guenther, R W ^b  

^a UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^b RWTH AACHEN UNIVERSITY   (Germany)

^c UNIVERSITY OF COLOGNE   (Germany)

^d SAARLAND UNIVERSITY   (Germany)

^e Epix Pharmaceuticals   (United States)

^f HARVARD MEDICAL SCHOOL   (United States)

^g TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Arteriosclerosis; Cardiac; Molecular imaging; MR imaging; Vascular

Indexed keywords

CONTRAST MEDIUM; EP 2104R; GADOLINIUM; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY THROMBOSIS; EX VIVO STUDY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SWINE;

ANIMALS; CONTRAST MEDIA; CORONARY THROMBOSIS; DISEASE MODELS, ANIMAL; GADOLINIUM; MAGNETIC RESONANCE IMAGING; PEPTIDES; SWINE;

EID: 36349017201     PISSN: 14389029     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-963573     Document Type: Article

References (47)

1. Falk E, Shah PK, Fuster V. Coronary plaque disruption. Circulation 1995; 92: 657-671
2. Rentrop KP. Thrombi in acute coronary syndromes: revisited and revised. Circulation 2000; 101: 1619-1626
3. Ojio S, Takatsu H, Tanaka T et al. Considerable time from the onset of plaque rupture and/or thrombi until the onset of acute myocardial infarction in humans: coronary angiographic findings within 1 week before the onset of infarction. Circulation 2000; 102: 2063-2069
4. Shinnar M, Fallon JT, Wehrli S et al. The diagnostic accuracy of ex vivo MRI for human atherosclerotic plaque characterization. Arterioscler Thromb Vasc Biol 1999; 19: 2756-2761
5. Johnstone MT, Botnar RM, Perez AS et al. In vivo magnetic resonance imaging of experimental thrombosis in a rabbit model. Arterioscler Thromb Vasc Biol 2001; 21: 1556-1560
6. Corti R, Osende JI, Fayad ZA et al. In vivo noninvasive detection and age definition of arterial thrombus by MRI. J Am Coll Cardiol 2002; 39: 1366-1373
7. Yuan C, Kerwin WS. MRI of atherosclerosis. J Magn Reson Imaging 2004; 19: 710-719
8. Moody AR, Murphy RE, Morgan PS et al. Characterization of complicated carotid plaque with magnetic resonance direct thrombus imaging in patients with cerebral ischemia. Circulation 2003; 107: 3047-3052
9. Fayad ZA, Fuster V, Fallon JT et al. Noninvasive In Vivo Human Coronary Artery Lumen and Wall Imaging Using Black-Blood Magnetic Resonance Imaging. Circulation 2000; 102: 506-510
10. Botnar RM, Stuber M, Kissinger KV et al. Noninvasive coronary vessel wall and plaque imaging with magnetic resonance imaging. Circulation 2000; 102: 2582-2587
11. Kim WY, Stuber M, Bornert P et al. Three-dimensional black-blood cardiac magnetic resonance coronary vessel wall imaging detects positive arterial remodeling in patients with nonsignificant coronary artery disease. Circulation 2002; 106: 296-299
12. Flacke S, Fischer S, Scott MJ et al. Novel MRI contrast agent for molecular imaging of fibrin: implications for detecting vulnerable plaques. Circulation 2001; 104: 1280-1285
13. Johansson LO, Bjornerud A, Ahlstrom HK et al. A targeted contrast agent for magnetic resonance imaging of thrombus: implications of spatial resolution. J Magn Reson Imaging 2001; 13: 615-618
14. Yu X, Song SK, Chen J et al. High-resolution MRI characterization of human thrombus using a novel fibrin-targeted paramagnetic nanoparticle contrast agent. Magn Reson Med 2000; 44: 867-872
15. Botnar RM, Perez AS, Witte S et al. In Vivo Molecular Imaging of Acute and Subacute Thrombosis Using a Fibrin-Binding Magnetic Resonance Imaging Contrast Agent. Circulation 2004; 109: 2023-2029
16. Botnar R, Buecker A, Wiethoff AJ et al. In vivo magnetic resonance imaging of coronary thrombosis using a fibrin-binding molecular magnetic resonance contrast agent. Circulation 2004; 110: 1463-1466
17. Spuentrup E, Buecker A, Katoh M et al. Molecular magnetic resonance imaging of coronary thrombosis and pulmonary emboli with a novel fibrin-targeted contrast agent. Circulation 2005; 22: 1377-1382
18. Sirol M, Fuster V, Badimon JJ et al. Chronic thrombus detection with in vivo magnetic resonance imaging and a fibrin-targeted contrast agent. Circulation 2005; 112: 1594-1600. Epub 2005
19. Spuentrup E, Katoh M, Wiethoff AJ et al. Molecular magnetic resonance imaging of pulmonary emboli with a fibrin-specific contrast agent. Am J Respir Crit Care Med 2005; 172: 494-500
20. Spuentrup E, Ruebben A, Schaeffter T et al. Magnetic resonance-guided coronary artery stent placement in a swine model. Circulation 2002; 105: 874-879
21. Spuentrup E, Buecker A, Stuber M et al. Navigator-gated coronary magnetic resonance angiography using steady-state-free-precession: comparison to standard t2-prepared gradient-echo and spiral imaging. Invest Radiol 2003; 38: 263-268
22. Fleckenstein JL, Archer BT, Barker BA et al. Fast short-tau inversion-recovery MR imaging. Radiology 1991; 179: 499-504
23. Kim WY, Danias PG, Stuber M et al. Coronary magnetic resonance angiography for the detection of coronary stenoses. N Engl J Med 2001; 345: 1863-1869
24. Botnar RM, Kim WY, Bornert P et al. 3D coronary vessel wall imaging utilizing a local inversion technique with spiral image acquisition. Magn Reson Med 2001; 46: 848-854
25. Choudhury RP, Fuster V, Badimon JJ et al. MRI and characterization of atherosclerotic plaque: emerging applications and molecular imaging. Arterioscler Thromb Vasc Biol 2002; 22: 1065-1074
26. Spuentrup E, Botnar RM. Coronary magnetic resonance imaging: visualization of the vessel lumen and the vessel wall and molecular imaging of arteriothrombosis. Eur Radiol 2006; 16: 1-14
27. Choudhury RP, Fuster V, Fayad ZA. Molecular, cellular and functional imaging of atherothrombosis. Nat Rev Drug Discov 2004; 3: 913-25
28. Bohm I, Heverhagen JT, Behe M et al. Molecular imaging of apoptosis in cardiovascular diseases. Fortschritt Röntgenstr 2007; 179: 780-789. Epub 2007
29. Grimm J, Wunder A. Current state of molecular imaging research. Fortschritt Röntgenstr 2005; 177: 326-337
30. Lee TH, Goldman L. Evaluation of the patient with acute chest pain. N Engl J Med 2000; 342: 1187-1195
31. Prasad A, Mathew V, Holmes DR Jr et al. Current management of non-ST-segment-elevation acute coronary syndrome: reconciling the results of randomized controlled trials. Eur Heart J 2003; 24: 1544-1553
32. Rittersma SZ, van der Wal AC, Koch KT et al. Plaque instability frequently occurs days or weeks before occlusive coronary thrombosis: a pathological thrombectomy study in primary percutaneous coronary intervention. Circulation 2005; 111: 1160-1165. Epub 2005
33. Libby P. Act local, act global: inflammation and the multiplicity of "vulnerable" coronary plaques. J Am Coll Cardiol 2005; 45: 1600-1602
34. Casscells W, Naghavi M, Willerson JT. Vulnerable atherosclerotic plaque: a multifocal disease. Circulation 2003; 107: 2072-2075
35. Maseri A, Fuster V. Is there a vulnerable plaque? Circulation 2003; 107: 2068-2071
36. Davies MJ. Stability and instability: two faces of coronary atherosclerosis. The Paul Dudley White Lecture 1995. Circulation 1996; 94: 2013-2020
37. Marder VJ, Chute DJ, Starkman S et al. Analysis of thrombi retrieved from cerebral arteries of patients with acute ischemic stroke. Stroke 2006; 37: 2086-2093. Epub 2006
38. Maintz D, Ozgun M, Hoffmeier A et al. Selective coronary artery plaque visualization and differentiation by contrast-enhanced inversion prepared MRI. Eur Heart J 2006; 27: 1732-1736. Epub 2006
39. Moody AR, Liddicoat A, Krarup K. Magnetic resonance pulmonary angiography and direct imaging of embolus for the detection of pulmonary emboli. Invest Radiol 1997; 32: 431-440
40. Paydarfar D, Krieger D, Dib N et al. In vivo magnetic resonance imaging and surgical histopathology of intracardiac masses: distinct features of subacute thrombi. Cardiology 2001; 95: 40-47
41. Kampschulte A, Ferguson MS, Kerwin WS et al. Differentiation of intraplaque versus juxtaluminal hemorrhage/thrombus in advanced human carotid atherosclerotic lesions by in vivo magnetic resonance imaging. Circulation 2004; 110: 3239-3244. Epub 2004
42. Fraser DG, Moody AR, Morgan PS et al. Diagnosis of lower-limb deep venous thrombosis: a prospective blinded study of magnetic resonance direct thrombus imaging. Ann Intern Med 2002; 136: 89-98
43. Saam T, Cai J, Ma L et al. Comparison of symptomatic and asymptomatic atherosclerotic carotid plaque features with in vivo MR imaging. Radiology 2006; 240: 464-472
44. Sitzer M, Muller W, Siebler M et al. Plaque ulceration and lumen thrombus are the main sources of cerebral microemboli in high-grade internal carotid artery stenosis. Stroke 1995; 26: 1231-1233
45. Nighoghossian N, Derex L, Douek P. The vulnerable carotid artery plaque: current imaging methods and new perspectives. Stroke 2005; 36: 2764-2772. Epub 2005
46. van Geuns RJ, Wielopolski PA, de Bruin HG et al. MR coronary angiography with breath-hold targeted volumes: preliminary clinical results. Radiology 2000; 217: 270-277
47. Nassenstein K, Waltering KU, Eggebrecht H et al. MR coronary angiography with MS-325, a blood pool contrast agent: comparison of an inversion recovery steady-state free precession with an inversion recovery fast low angle shot sequence in volunteers. Fortschr Röntgenstr 2006; 178: 508-514. Epub 2006